2023 annual financial data
Atea Pharmaceuticals 2023 Operating margin
Atea Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -164,162,000 USD and net income was -135,956,000 USD.
Operating cash flow was -85,395,000 USD.
Get free Atea Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -164,162,000 USD
- Net income
- -135,956,000 USD
- Operating cash flow
- -85,395,000 USD